Sarepta Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,959	71,833	43,771	60,134	43,689	69,869
Market Cap Growth	-84.76%	64.11%	-27.21%	37.64%	-37.47%	80.70%
Enterprise Value	12,084	73,172	42,102	57,659	41,339	64,510
Last Close Price	4.74	37.28	22.96	32.50	23.98	38.47
PE Ratio	-	49.37	-	-	-	-
PS Ratio	0.77	6.11	7.26	12.19	11.17	24.91
PB Ratio	1.42	7.60	10.50	29.55	8.45	17.66
P/TBV Ratio	1.45	7.74	10.87	30.14	8.58	17.98
P/FCF Ratio	-	-	-	-	-	532.53
P/OCF Ratio	-	-	-	-	-	125.19
EV/Sales Ratio	0.96	6.22	6.98	11.69	10.57	23.00
EV/EBITDA Ratio	24.81	46.25	-	-	-	-
EV/EBIT Ratio	-	54.25	-	-	-	-
EV/FCF Ratio	-5.95	-	-	-	-	491.69
Debt / Equity Ratio	0.96	0.88	1.61	4.20	1.23	1.41
Debt / EBITDA Ratio	13.43	3.74	-	-	-	-
Debt / FCF Ratio	-	-	-	-	-	42.47
Asset Turnover	0.68	0.53	0.39	0.30	0.23	0.23
Inventory Turnover	2.40	2.10	3.90	5.21	4.12	3.90
Quick Ratio	1.51	2.74	3.23	3.63	5.05	4.99
Current Ratio	2.95	4.20	3.95	4.13	5.75	5.97
Return on Equity (ROE)	-21.37%	19.71%	-86.15%	-107.16%	-49.57%	-70.14%
Return on Assets (ROA)	-1.52%	3.77%	-5.24%	-10.68%	-9.04%	-14.67%
Return on Invested Capital (ROIC)	-4.71%	18.93%	-93.16%	-	-	-353.53%
Return on Capital Employed (ROCE)	-3.30%	6.70%	-10.30%	-21.40%	-16.50%	-22.00%
Earnings Yield	-14.53%	2.02%	-5.94%	-6.19%	-5.34%	-4.12%
FCF Yield	-20.39%	-2.95%	-6.40%	-3.13%	-6.14%	0.19%
Buyback Yield / Dilution	2.62%	-16.75%	-5.53%	-7.75%	-4.24%	-5.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.